McDonald’s Corp. has finally updated its antibiotics policy that calls for reduced antibiotic usage after a two-year delay.
The fast-food giant’s new policy revealed in Decemebr follows guidelines set out by the World Health Organization (WHO), the World Organization for Animal Health, and other public and animal health groups.
According to McDonald’s, they will focus on the responsible use of medically important antibiotics and be aligned with WHO Guidelines on Antimicrobial Resistance.
The company added that its policy does not permit the routine use of medically important antibiotics for growth promotion or tdisease prevention.
It is committed to usage reduction, where possible without adverse effects on animal health and welfare.
The company has established market-specific targets for the responsible use of antibiotics for 10 in-scope markets, representing over 80 percent of its global beef supply chain.
In 2023, McDonald’s plans to share an update on its antibiotic usage.
However, the Natural Resources Defense Council (NRDC) criticized McDonald’s for failing to detail a rollout plan or a completion date to ensure accountability across the supply chain.
According to Lena Brook, director of food campaigns at NRDC, it is especially disappointing given that McDonald’s, the world’s largest beef buyer, chose optics over substance with its new beef policy update despite the urgency of the global antibiotic resistance crisis.
McDonald’s earned a grade of C from the NDRC for its previous policy. NDRC called McDonald’s updated policy a “new, weaker approach.”


AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback
Sony, TSMC Eye $6.3 Billion Japan Chip Venture for Next-Gen Image Sensors
Austal Shares Surge 16% as Hanwha Offers Up to $1.2 Billion for U.S. Shipbuilding Business
Airbus Joins Air India A320 Altitude Drop Probe
JPMorgan Plans More Asia-Pacific Hiring in 2027 as Corporate Banking Revenue Surges
Trump Administration Bars U.S. Travelers From Congo Flights Amid Ebola Outbreak
Nintendo Shares Jump as Switch 2 Sales Boost Earnings
US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations
Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
The government is ‘doubling down’ on its social media ban. But bigger penalties for platforms aren’t enough
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Shein Scales Back Vietnam Operations as US Trade Rules Shift
Venezuela Earthquake Health Risks Rise as Disease Monitoring Intensifies
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme 



